The registration presents on “the aluminum of the brochure can lend confusing” on the dosage, justifies the national drug safety agency.
More than 32,000 boxes of a generic drug against hypertension and heart failure, Lisinopril, were recalled in France due to a “Printing defect” on platelets “That can induce a risk of overdose”the National Agency for Medicines Safety (ANSM) said on Tuesday. The quality of the tablets marketed by the American laboratory Viatris “Is not called into question” more “The inscription present on the aluminum of the brochure can lend confusing because it suggests that it is necessary to take several tablets certain days”specifies the ANSM in a press release.
In total, four Lisinopril lots dosed at 5 mg are affected (lots 8172295, 8189879, 8172296, 8192737), or 32,640 boxes, according to a count obtained from the ANSM. In case of overdose, it is possible to feel fatigue, balance disorders, hypotension and “An alteration of the renal function can occur”warns the Medicines’s Guardian.
A case of overdose accompanied by an unworthy confusing state has been reported, according to the ANSM. While waiting for new lots with compliant plates to be “Soon available”no supply tension in Lisinopril is provided for following this recall, according to the agency, because “Alternatives are available”. Other genericers, such as Biogaran, Teva, Zentiva, Sandoz or Arrow offer this molecule, according to the Vidal Data Database in France.
